Skip to main content
. 2021 Apr 30;9(3):e00767. doi: 10.1002/prp2.767

TABLE 1.

Participant characteristics at baseline

Characteristic Number (%)
Alcohol use disorder (n = 10) Methamphetamine use disorder (n = 8)
Country of birth
Australia 8 (80.0) 6 (75.0)
Other 2 (20.0) (Yugoslavia, United Kingdom) 2 (25.0) (Scotland, South Africa)
Indigenous Australian 1 (10.0) 0
Living status
Alone 4 (40.0) 2 (25.0)
Partner (with at least 1 child) 3 (30.0) 2 (25.0)
Partner (no children) 2 (20.0) 1 (12.5)
Relationship status
Single 4 (40.0) 5 (62.5)
Living with spouse (including married, de facto, life partner) 4 (40.0) 3 (37.5)
Separated but not divorced 2 (20.0) 0
Accommodation
Private accommodation 10 (100.0) 8 (100.0)
Employment
Employed 4 (40.0) 4 (80.0)
Disability support pension 2 (20.0) 1 (12.5)
Currently unemployed 1 (10.0) 1 (10.0)
Highest level of education
Secondary (years 7–10) 2 (10.0) 3 (37.5)
Secondary (years 11–12) 1 (10.0) 3 (37.5)
Tertiary 6 (60.0) 1 (12.5)
Post graduate 1 (10.0) 1 (12.5)
Medical history
Current conditions
Depression 4 (40.0%) 3 (37.5%)
Anxiety 4 (40.0%) 3 (37.5%)
High cholesterol 2 (20.0%) 0
Alcohol‐related conditions
None 7 (70.0%) 6 (75.0%)
Seizures 2 (20.0%) 0
Alcohol or methamphetamine use history Alcohol use Methamphetamine use
Estimated amount (standard drinks) Estimated amount (g)
Mean (SE) 21.8 (4.4) 0.66 (0.22)
Age at first drink (years) Age at first use (years)
Mean (SE) 16.3 (0.4) 24.0 (3.1)
Age at daily drinking (years) Age at problematic use (years)
Mean (SE) 31.6 (2.8) 25.7 (3.4)
Duration since daily drinking (years) Duration since problematic use (years)
Mean (SE) 15.8 (2.5) 10.4 (2.5)
Previous detoxifications
At least 1 detoxification 9 (90.0%) 4 (50.0%)
Previous withdrawal symptoms
Sweating 9 (15.0%) 1 (1.7%)
Anxiety 8 (13.3%) 3 (5.0%)
Tremor 7 (11.7%) 1 (1.7%)
Nausea 5 (8.3%) 0
Agitation 5 (8.3%) 3 (5.0%)
Seizures 2 (3.3%) 0
Vomiting 3 (5.0%) 0
Diarrhea 2 (3.3%) 0
Delirium tremens 1 (1.7%) 0
Previous treatment for dependence
At least 1 treatment 9 (90.0%) 4 (50.0%)
Previous types of treatment (often multiple)
Counseling 9 (100.0%) 4 (100.0%)
Acamprosate maintenance 9 (100.0%) 0
Naltrexone maintenance 8 (88.9%) 0
Alcoholics anonymous (AA) 7 (77.8%) 0
Residential rehabilitation activities 4 (44.4%) 1 (25.0%)
Disulfiram maintenance 2 (22.2%) 0
Other 3 (33.3%) (recovery and support program, 2× baclofen) 1 (25.0%) (The Rewired Program—self‐administered)